ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.641,68
0,82%
S&P 500
6.051,62
0,43%
US Dollar vs BRL
5,7905
-0,27%
Bitcoin
97.630,79
1,17%
Brent Oil
75,34
0,96%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Enovis Corporation (ENOV)

  7. Enovis Corporation (ENOV) Notícias

ENOV

Enovis (ENOV)

Enovis Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:ENOV
DataHoraFonteTítuloCódigoCompanhia
29/01/202509:00GlobeNewswire Inc.Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26thNYSE:ENOVEnovis Corporation
28/01/202509:17Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENOVEnovis Corporation
28/01/202508:51Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NYSE:ENOVEnovis Corporation
17/01/202508:00GlobeNewswire Inc.Enovis™ Announces Leadership Change to International Surgical BusinessNYSE:ENOVEnovis Corporation
07/01/202520:19PR Newswire (US)Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600NYSE:ENOVEnovis Corporation
06/01/202518:15GlobeNewswire Inc.Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:ENOVEnovis Corporation
18/11/202418:10GlobeNewswire Inc.Enovis to Participate in Upcoming Investor ConferencesNYSE:ENOVEnovis Corporation
14/11/202415:28Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:ENOVEnovis Corporation
06/11/202418:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENOVEnovis Corporation
06/11/202408:00GlobeNewswire Inc.Enovis Announces Third Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
10/10/202408:00GlobeNewswire Inc.Enovis to Host Third Quarter 2024 Results Conference Call on November 6thNYSE:ENOVEnovis Corporation
09/09/202416:50GlobeNewswire Inc.Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling TechnologiesNYSE:ENOVEnovis Corporation
05/09/202409:00GlobeNewswire Inc.Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual MeetingNYSE:ENOVEnovis Corporation
20/08/202409:00GlobeNewswire Inc.Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision ProceduresNYSE:ENOVEnovis Corporation
19/08/202409:00GlobeNewswire Inc.Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched DurabilityNYSE:ENOVEnovis Corporation
07/08/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENOVEnovis Corporation
07/08/202407:00GlobeNewswire Inc.Enovis Announces Second Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
25/07/202407:00GlobeNewswire Inc.Enovis Announces Time Change for Second Quarter 2024 Results Conference CallNYSE:ENOVEnovis Corporation
16/07/202408:00GlobeNewswire Inc.Enovis to Host Second Quarter 2024 Results Conference Call on August 7thNYSE:ENOVEnovis Corporation
12/07/202409:00GlobeNewswire Inc.Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®NYSE:ENOVEnovis Corporation
31/05/202417:05Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:ENOVEnovis Corporation
02/05/202407:00GlobeNewswire Inc.Enovis Announces First Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
17/04/202408:00GlobeNewswire Inc.Enovis to Host First Quarter 2024 Results Conference Call on May 2ndNYSE:ENOVEnovis Corporation
28/03/202408:00GlobeNewswire Inc.Enovis to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNYSE:ENOVEnovis Corporation
22/02/202408:57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:ENOVEnovis Corporation
22/02/202408:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENOVEnovis Corporation
22/02/202408:00GlobeNewswire Inc.Enovis Announces Fourth Quarter and Full Year 2023 ResultsNYSE:ENOVEnovis Corporation
21/02/202418:48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:ENOVEnovis Corporation
14/02/202412:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENOVEnovis Corporation
12/02/202413:30GlobeNewswire Inc.Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual MeetingNYSE:ENOVEnovis Corporation
 Apresentando as notícias mais relevantes sobre:NYSE:ENOV

Seu Histórico Recente

BOV
INEP4R
INEPAR PN
BIT
P1LO76
BNP Paribas Issuance
BIT
Q00585
Leonteq Securities
BIT
P1NO74
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios